Ionis Pharmaceuticals, Inc.

US$39.42As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IONSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.25%
Div yield —
ROE (105.50%)
Biotechnology
Beta (5Y) 0.40
PE TTM —
TSR TTM (46.94%)
Mkt cap US$6.551B
ROIC (72.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$48
22.87%
5.44%
Hold 5|0|8|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.49
0.52
0.55
0.60
(1.71%)
8.96%
16.46%
21.39%
Revenue$M
309.2
304.4
303.3
304.2
9.95%
4.43%
6.56%
1.75%
Peers (US$6.551B)
Cap (US$)
PE
6.787B
—
6.306B
—
Capital
TTM
5Y
10Y
Leveragex
0.050
0.375
0.386
EBIT/Intx
2.129
0.788
0.582
Own earn%
10.28
11.43
3.13
Sh yield%
18.75
54.30
54.03
Owners
Insiders/Inst%
6.40
69.30
Short interest%
0.95
SBC / revenue%
0.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
27–33
$1 testx
0.3
Incr. ROIC%
14